These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 23910443)
1. Post-interventional cardiac biomarker release has lower prognostic relevance compared with standard risk markers in patients with stable coronary artery disease undergoing elective percutaneous coronary interventions. Brauer M; Bode E; Metzler B; Alber H; Mair J Int J Cardiol; 2013 Oct; 168(5):4864-5. PubMed ID: 23910443 [No Abstract] [Full Text] [Related]
2. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654 [TBL] [Abstract][Full Text] [Related]
3. Risk stratification in stable coronary artery disease: superiority of N-terminal pro B-type natriuretic peptide over high-sensitivity C-reactive protein, gamma-glutamyl transferase, and traditional risk factors. Bode E; Wuppinger T; Bode T; Alber H; Ulmer H; Pachinger O; Mair J Coron Artery Dis; 2012 Mar; 23(2):91-7. PubMed ID: 22157356 [TBL] [Abstract][Full Text] [Related]
4. Association of N-terminal pro-brain natriuretic peptide and cardiac troponin T with in-hospital cardiac events in elderly patients undergoing coronary artery surgery. Suttner S; Boldt J; Lang K; Röhm KD; Piper SN; Mayer J Eur J Anaesthesiol; 2008 Oct; 25(10):834-41. PubMed ID: 18471334 [TBL] [Abstract][Full Text] [Related]
5. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial). Bonaca MP; Wiviott SD; Sabatine MS; Buros J; Murphy SA; Scirica BM; Rifai N; Antman EM; Morrow DA Am J Cardiol; 2007 Feb; 99(3):344-8. PubMed ID: 17261395 [TBL] [Abstract][Full Text] [Related]
6. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. James SK; Lindahl B; Siegbahn A; Stridsberg M; Venge P; Armstrong P; Barnathan ES; Califf R; Topol EJ; Simoons ML; Wallentin L Circulation; 2003 Jul; 108(3):275-81. PubMed ID: 12847065 [TBL] [Abstract][Full Text] [Related]
7. Association between anxiety and C-reactive protein levels in stable coronary heart disease patients. Bankier B; Barajas J; Martinez-Rumayor A; Januzzi JL Psychosomatics; 2009; 50(4):347-53. PubMed ID: 19687175 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. Omland T; Pfeffer MA; Solomon SD; de Lemos JA; Røsjø H; Šaltytė Benth J; Maggioni A; Domanski MJ; Rouleau JL; Sabatine MS; Braunwald E; J Am Coll Cardiol; 2013 Mar; 61(12):1240-9. PubMed ID: 23414791 [TBL] [Abstract][Full Text] [Related]
9. Sensitive troponin and N-terminal probrain natriuretic peptide in stable angina. Ndrepepa G; Braun S; Schulz S; Fusaro M; Keta D; Pache J; Seyfarth M; Mehilli J; Schömig A; Kastrati A Eur J Clin Invest; 2011 Oct; 41(10):1054-62. PubMed ID: 21413976 [TBL] [Abstract][Full Text] [Related]
10. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients. Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079 [TBL] [Abstract][Full Text] [Related]
11. Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation: a substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYNTAX) Trial. Farooq V; Serruys PW; Vranckx P; Bourantas CV; Girasis C; Holmes DR; Kappetein AP; Mack M; Feldman T; Morice MC; Colombo A; Morel MA; de Vries T; Dawkins KD; Mohr FW; James S; Ståhle E Int J Cardiol; 2013 Oct; 168(6):5287-92. PubMed ID: 23993326 [TBL] [Abstract][Full Text] [Related]
12. Correlations between cardiac troponin I, cardiac troponin T, and creatine phosphokinase MB elevation following successful percutaneous coronary intervention and prognostic value of each marker. Okmen E; Kasikcioglu H; Sanli A; Uyarel H; Cam N J Invasive Cardiol; 2005 Feb; 17(2):63-7. PubMed ID: 15687525 [TBL] [Abstract][Full Text] [Related]
13. Prognostic importance of troponin T and creatine kinase after elective angioplasty. Nienhuis MB; Ottervanger JP; Dikkeschei B; Suryapranata H; de Boer MJ; Dambrink JH; Hoorntje JC; van 't Hof AW; Gosselink M; Zijlstra F Int J Cardiol; 2007 Aug; 120(2):242-7. PubMed ID: 17182137 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the usefulness of N-terminal pro-brain natriuretic peptide to other serum biomarkers as an early predictor of ST-segment recovery after primary percutaneous coronary intervention. Verouden NJ; Haeck JD; Kuijt WJ; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; van Straalen JP; Fischer J; Piek JJ; Tijssen JG; de Winter RJ Am J Cardiol; 2010 Apr; 105(8):1047-52. PubMed ID: 20381651 [TBL] [Abstract][Full Text] [Related]
15. High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial. Harutyunyan MJ; Mathiasen AB; Winkel P; Gøtze JP; Hansen JF; Hildebrandt P; Jensen GB; Hilden J; Jespersen CM; Kjøller E; Kolmos HJ; Gluud C; Kastrup J; Scand J Clin Lab Invest; 2011 Feb; 71(1):52-62. PubMed ID: 21108561 [TBL] [Abstract][Full Text] [Related]
16. Links between sleep disordered breathing, coronary atherosclerotic burden, and cardiac biomarkers in patients with stable coronary artery disease. Inami T; Seino Y; Otsuka T; Yamamoto M; Kimata N; Murakami D; Takano M; Ohba T; Ibuki C; Mizuno K J Cardiol; 2012 Sep; 60(3):180-6. PubMed ID: 22525967 [TBL] [Abstract][Full Text] [Related]
17. The prognostic value of pre-procedural plasma C-reactive protein in patients undergoing elective coronary angioplasty. de Winter RJ; Heyde GS; Koch KT; Fischer J; van Straalen JP; Bax M; Schotborgh CE; Mulder KJ; Sanders GT; Piek JJ; Tijssen JG Eur Heart J; 2002 Jun; 23(12):960-6. PubMed ID: 12069451 [TBL] [Abstract][Full Text] [Related]
18. Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis. Gravning J; Smedsrud MK; Omland T; Eek C; Skulstad H; Aaberge L; Bendz B; Kjekshus J; Mørkrid L; Edvardsen T Am Heart J; 2013 May; 165(5):716-24. PubMed ID: 23622908 [TBL] [Abstract][Full Text] [Related]
19. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure. de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860 [TBL] [Abstract][Full Text] [Related]
20. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure. Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]